7-Hydroxy-N-(3-hydroxy-1-((10-hydroxy-5-methyl-2,7-dioxo-1,6-diazacyclododec-3-en-8-yl)amino)-1-oxobutan-2-yl)dodeca-2,4-dienamide

Catalog No. :
ACHGWU473
CAS No. :
119259-74-4
Molecular Formula :
C27H44N4O7
Molecular Weight :
536.67

IUPAC Name:7-hydroxy-N-(3-hydroxy-1-((10-hydroxy-5-methyl-2,7-dioxo-1,6-diazacyclododec-3-en-8-yl)amino)-1-oxobutan-2-yl)dodeca-2,4-dienamide

7-Hydroxy-N-(3-hydroxy-1-((10-hydroxy-5-methyl-2,7-dioxo-1,6-diazacyclododec-3-en-8-yl)amino)-1-oxobutan-2-yl)dodeca-2,4-dienamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name7-Hydroxy-N-(3-hydroxy-1-((10-hydroxy-5-methyl-2,7-dioxo-1,6-diazacyclododec-3-en-8-yl)amino)-1-oxobutan-2-yl)dodeca-2,4-dienamide
IUPAC Name7-hydroxy-N-(3-hydroxy-1-((10-hydroxy-5-methyl-2,7-dioxo-1,6-diazacyclododec-3-en-8-yl)amino)-1-oxobutan-2-yl)dodeca-2,4-dienamide
Molecular FormulaC27H44N4O7
Molecular Weight536.67
SMILESCCCCCC(O)CC=CC=CC(=O)NC(C(=O)NC1CC(O)CCNC(=O)C=CC(C)NC1=O)C(C)O
InChI KeyDCOUSTGIABFBAL-UHFFFAOYSA-N
Synonymglidobactin E;2,4-Dodecadienamide, 7-hydroxy-N-[2-hydroxy-1-[[(10-hydroxy-5-methyl-2,7-dioxo-1,6-diazacyclododec-3-en-8-yl)amino]carbonyl]propyl]- (9CI)
CAS No.119259-74-4

Synthetic Route by SureRoute

1. ACHGWU473 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACHGWU473 route product structure diagram
    ACHGWU473119259-74-4
Inquiry

2. ACHGWU473 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACHGWU473 route product structure diagram
    ACHGWU473119259-74-4
Inquiry

Comments (0)